PubRank

Alexander Kutikov

Author PubWeight™ 71.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol 2011 2.87
2 Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology 2011 2.20
3 Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 2011 1.98
4 Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy. Urology 2010 1.77
5 Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes. Chem Biol 2004 1.66
6 Trends in regionalization of adrenalectomy to higher volume surgical centers. J Urol 2012 1.64
7 Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology 2012 1.54
8 Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment. Urology 2013 1.49
9 Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU Int 2014 1.47
10 Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology 2011 1.46
11 Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Can J Urol 2012 1.45
12 Robot-assisted partial nephrectomy: a large single-institutional experience. Urology 2010 1.45
13 Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care. BJU Int 2013 1.41
14 Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma. J Urol 2012 1.40
15 How Hugh Hampton Young's treatment of President Woodrow Wilson's urinary retention and urosepsis affected the resolution of World War I. J Urol 2011 1.38
16 Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy. BJU Int 2011 1.31
17 Zinc and zinc transporters in prostate carcinogenesis. Nat Rev Urol 2013 1.11
18 Modulation of Akt/mTOR signaling overcomes sunitinib resistance in renal and prostate cancer cells. Mol Cancer Ther 2012 1.09
19 Perioperative outcomes of robotic and open partial nephrectomy for moderately and highly complex renal lesions. J Urol 2012 1.01
20 Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. Prostate 2012 1.00
21 Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells. Prostate 2013 0.99
22 Renal masses herniating into the hilum: technical considerations of the "ball-valve phenomenon" during nephron-sparing surgery. Urology 2009 0.96
23 Does partial nephrectomy result in a durable overall survival benefit in the Medicare population? J Urol 2012 0.96
24 Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database. Can J Urol 2013 0.95
25 Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. BJU Int 2012 0.94
26 The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer 2014 0.94
27 Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates. J Urol 2013 0.94
28 Should partial nephrectomy be offered to all patients whenever technically feasible? Eur Urol 2011 0.92
29 Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy. J Urol 2012 0.89
30 Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009. Urol Oncol 2012 0.88
31 Metanephric adenofibroma: robotic partial nephrectomy of a large Wilms' tumor variant. Can J Urol 2010 0.87
32 Is radical nephrectomy a legitimate therapeutic option in patients with renal masses amenable to nephron-sparing surgery? BJU Int 2014 0.86
33 A case of synchronous bilateral testicular seminoma. Nat Clin Pract Urol 2008 0.85
34 Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised? BJU Int 2010 0.85
35 Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members. J Urol 2013 0.84
36 Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells. Carcinogenesis 2011 0.84
37 Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital type. BJU Int 2014 0.84
38 Docetaxel-mediated apoptosis in myeloid progenitor TF-1 cells is mitigated by zinc: potential implication for prostate cancer therapy. Prostate 2011 0.83
39 Prostate bed motion during intensity-modulated radiotherapy treatment. Int J Radiat Oncol Biol Phys 2012 0.83
40 Are all multi-targeted tyrosine kinase inhibitors created equal? An in vitro study of sunitinib and pazopanib in renal cell carcinoma cell lines. Can J Urol 2011 0.83
41 Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity. Prostate 2011 0.83
42 Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas. Urology 2011 0.82
43 Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism. Mol Cancer 2010 0.81
44 Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference? BJU Int 2011 0.80
45 RENAL nephrometry scoring system: the radiologist's perspective. AJR Am J Roentgenol 2012 0.80
46 Implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT. Can J Urol 2010 0.79
47 Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis. J Urol 2012 0.79
48 Partial versus radical nephrectomy: balancing nephrons and perioperative risk. Eur Urol 2013 0.79
49 Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy. Urol Oncol 2011 0.79
50 Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma. Cancer Biol Ther 2015 0.78
51 Delayed proximal ureteric stricture formation after complex partial nephrectomy. BJU Int 2011 0.78
52 The effect of 5-aminolevulinic acid and its derivatives on protoporphyrin IX accumulation and apoptotic cell death in castrate-resistant prostate cancer cells. Urology 2012 0.78
53 Adrenocortical carcinoma masquerading as a benign adenoma on computed tomography washout study. Urology 2011 0.78
54 Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy. Brachytherapy 2011 0.78
55 Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer. Radiother Oncol 2011 0.77
56 Coupling of prostate and thyroid cancer diagnoses in the United States. Ann Surg Oncol 2014 0.77
57 The clinical and pathological history of prostate cancer progression in men with a prior history of high grade prostatic intraepithelial neoplasia. Can J Urol 2008 0.77
58 Is there a benefit to frozen section analysis at the time of partial nephrectomy? Can J Urol 2013 0.77
59 Transrectal implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT. Can J Urol 2011 0.76
60 Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data. Med Care 2016 0.76
61 Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis. Urol Oncol 2011 0.76
62 Thermal ablation of the small renal mass: case selection using the R.E.N.A.L.-Nephrometry Score. Urol Oncol 2012 0.76
63 Management of small renal masses. Semin Ultrasound CT MR 2009 0.76
64 Kidney cancer: assessing the management of localized kidney cancer. Nat Rev Urol 2012 0.75
65 Meaningful comparison of robotics versus laparoscopy for nephron-sparing surgery: no contest or no dice? Eur Urol 2012 0.75
66 Does every second really count when it comes to renal ischemia during nephron sparing surgery? Can J Urol 2014 0.75
67 The role of minimally invasive surgery in multifocal renal cell carcinoma. Curr Urol Rep 2012 0.75
68 Andrew Johnson's rocky medical and political 'calculous'. BJU Int 2010 0.75
69 Prolonged natural progression from localized to symptomatic renal cell carcinoma. Can J Urol 2012 0.75
70 How Chester Alan Arthur 'brightened' from a political spoilsman to a civil service reformer. BJU Int 2011 0.75
71 Modern management of pheochromocytoma. Nat Clin Pract Urol 2007 0.75
72 Patient reported outcomes among treatment modalities for prostate cancer. Can J Urol 2016 0.75
73 Intensely positron emission tomography-avid benign adrenal adenoma. Urology 2011 0.75